> CAT CONTACT :: EDITORIAL CHANNEL ONLY
Contact TB-500 Script — editorial corrections and source queries.
A channel for citation corrections and source suggestions on the TB-500 record. Not a clinical service, not a sales desk.
What this channel is for
Use this channel for editorial matters about the TB-500 and thymosin beta-4 research record: a citation that resolves wrong, a study we should index, a figure that needs correcting, or a question about how we read a source. We take accuracy seriously — if a number on this site does not match its cited study, we want to know, and we will fix it.
What this channel is not: it is not a clinical service, and it is not a sales desk. We cannot offer medical advice, we cannot recommend a dose, and we do not sell, supply, or source any substance. Inquiries asking where to obtain TB-500, what to take, or how to use it fall outside what this editorial project can answer — those are clinical and commercial questions, and this is neither a clinic nor a vendor.
Before you write
If your question is about the evidence, the answer may already be logged. The human clinical trials on TB-500 section covers the trial record, the TB-500 dosage in the research literature page covers what studies administered, and the TB-500 legal status and 503A category page covers the FDA and WADA standing. The frequently asked questions about TB-500 page collects the short-form answers.
For everything else editorial, the form below reaches the project. We read what comes in, and we prioritize corrections to cited claims. Please include the page and the citation number where relevant — it helps us verify and respond faster.